METHODS: A total of 72 cases were randomly treated with pevisone(group A) or momiqi(group B) for 3 consecutive weeks.

• 方法:72例患者分为两组,A组给予派瑞松,B组给予摩弥齐,均连用3周,初诊当日和用药第1、2、3周检查记录,评价疗效。